List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #40,401 to #40,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. PREAMI → Perindopril Remodeling In Elderly With Acute Myocardial Infarction
  2. PRECISE → Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
  3. PREDICT → Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
  4. PREMIAR → Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
  5. PREMIER → Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
  6. PREPAIR → Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
  7. PREPARE — Presented at TCT 2008 → Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
  8. PREPIC → A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
  9. PRESENT → Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
  10. PRESERVE → Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
  11. PRESTO → Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
  12. PREVEND IT → Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
  13. PREVENT(Radiation) → Proliferation Reduction With Vascular Energy Trial
  14. PREVENT (Dalteparin) → Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  15. PREVENT (Warfarin) → Venous thromboembolism
  16. PREVENT II → The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
  17. PREVENT IV → Project Of Ex-Vivo Vein Graft Engineering Via Transfection
  18. PRF1 → Perforin
  19. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  20. PRIMA — Presented at ACC.09/i2 → Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  21. PRIME-2 → Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  22. PRIMI → Pro-Urokinase For Myocardial Infarction
  23. PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  24. PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  25. PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
  26. PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  27. PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
  28. PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
  29. PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  30. PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
  31. PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
  32. PRKACB gene → PRKACB
  33. PRKAR1A gene → PRKAR1A
  34. PRL cell adenoma → Prolactinoma
  35. PRL cell tumor → Prolactinoma
  36. PRL secreting adenoma → Prolactinoma
  37. PRL secreting pituitary adenoma → Prolactinoma
  38. PRL tumor → Prolactinoma
  39. PRNT → Plaque reduction neutralization test
  40. PROCAM → Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
  41. PRODH → Proline oxidase
  42. PROFILE → Prospective Randomized Flosequinan Longevity Evaluation
  43. PROGRESS → Perindopril Protection Against Recurrent Stroke Study
  44. PROGRESS-1 → Coronary Stenting With Absorbable Metal Stents
  45. PROLONG study → PROLONG Study
  46. PROM → Premature rupture of membranes
  47. PROMM → Myotonic dystrophy
  48. PROSPER → PROSPER Trial
  49. PROTECT-CAD → Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
  50. PROTECT - TIMI 30 → Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents

View ( | ) (20 | 50 | 100 | 250 | 500)